Preparation method of evocamide ethyl ester
Through the improved preparation method of evocaser ethyl ester, the reaction of (R)-1-BOC-3-hydroxypyrrolidine and 2-nitrobenzenesulfonyl chloride was solved by using the use of ethanol hydrochloride and sodium tert-butoxide. Genotoxic impurities and high cost problems in the existing processes have achieved efficient and low-cost synthesis of evocassel ethyl ester.
Patent Information
- Application Number
- CN202411013626.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-12-06
AI Technical Summary
In the existing synthesis process of evocass, there are problems such as the use of genotoxic impurity acetyl chloride, low purity of intermediates, and high production costs due to the high cesium carbonate.
Intermediate 2 was prepared by reacting (R)-1-BOC-3-hydroxypyrrolidine with 2-nitrobenzenesulfonyl chloride, followed by reaction with (R)-1-(1-naphthyl)ethylamine, using ethanol hydrochloride solution As the deprotection reagent, the coupling reaction was carried out by treatment with inorganic base and sodium tert-butoxide or potassium tert-butoxide as acid binding agent, palladium acetate and X-phos as catalysts.
Simplified operation, reduced the risk of isopropanol mixing, reduced material costs, shortened reaction time and reduced energy consumption, and improved the purity and reaction efficiency of the intermediate.
Smart Images

Figure CN119080664A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pharmaceutical synthesis, and in particular to a method for preparing evokase ethyl ester. Background Art
[0002] Evocalcet is a new type of calcimimetic discovered by Mitsubishi Tanabe Pharma Corporation. In 2008, Kyowa Kirin signed a licensing agreement to obtain the rights to jointly research, develop, sell and produce evocalcet in Japan and parts of Asia.
[0003] As a second-generation cinacalcet (a calcimimetic that has been approved for marketing), ivocacet can not only effectively reduce parathyroid hormone, blood calcium and FGF23, and reduce blood phosphorus by inhibiting bone dissolution; at the same time, it has significantly improved the bioavailability of the drug and greatly reduced gastrointestinal side effects and interactions with other drugs.
[0004] For the synthesis of ivocacet, CN105517992B of Mitsubishi Tanabe Corporation lists the corresponding synthesis process, and the reaction formula is shown in the figure below:
[0005]
[0006] This route is simple to operate and has high feasibility. However, there are some shortcomings: 1. The use of acetyl chloride and isopropanol to prepare hydrochloric acid isopropanol solution increases the genotoxic impurity acetyl chloride; 2. The precipitated intermediate 4 has a low purity, resulting in more impurities in the reaction solution in the subsequent coupling step and difficulty in purification; 3. The coupling reaction uses cesium carbonate as a base, which is expensive and has a high production cost. Summary of the invention
[0007] 1. Technical problems to be solved:
[0008] In view of the above technical problems, the present invention provides a method for preparing evokedrin ethyl ester.
[0009] 2. Technical solution:
[0010] A preparation method of evokedrin ethyl ester, the reaction route of the preparation method is as follows:
[0011]
[0012] The preparation method comprises the following steps:
[0013] S1: (R)-1-BOC-3-hydroxypyrrolidine and 2-nitrobenzenesulfonyl chloride were reacted to prepare intermediate 2;
[0014] S2: Intermediate 2 reacts with (R)-1-(1-naphthyl)ethylamine to prepare intermediate 3;
[0015] S3: intermediate 3 uses hydrochloric acid ethanol solution as a deprotection reagent to prepare intermediate 4;
[0016] S4: Intermediate 4 is converted from an ammonium salt to an amine by treatment with an inorganic base and then added to toluene or xylene, sodium tert-butoxide or potassium tert-butoxide is added as an acid-binding agent, palladium acetate is used as a catalyst, and X-phos is used as a ligand of the catalyst. Ethyl p-bromophenylacetate is added dropwise in the range of -5°C to room temperature for coupling reaction, and the temperature is maintained at -5°C to room temperature and stirred until the reaction is completed. Hydrochloric acid and ethanol are added dropwise to convert the product into an ammonium salt, and the temperature is lowered to 0±5°C. Methyl tert-butyl ether is added dropwise to precipitate a solid ammonium salt to obtain intermediate 5; intermediate 5 is further converted from an ammonium salt to an amine by treatment with an inorganic base to obtain ivocate ethyl ester.
[0017] Preferably, the molar ratio of sodium tert-butoxide or potassium tert-butoxide to intermediate 4 is 1.2 to 1.5.
[0018] Furthermore, the specific steps of S1 include: adding (R)-1-BOC-3-hydroxypyrrolidine to a solvent DCM, then adding trimethylamine hydrochloride and triethylamine, cooling to -5 to 0°C, maintaining the internal temperature at 5±5°C, dropwise adding a DCM solution of 2-nitrobenzenesulfonyl chloride thereto, continuing to maintain the internal temperature at 5±5°C while stirring the reaction until the (R)-1-BOC-3-hydroxypyrrolidine reacts completely, quenching with water, separating the liquids and concentrating to obtain intermediate 2.
[0019] Furthermore, the specific steps of S2 include: adding the unpurified intermediate 2 of S1 to acetonitrile, then adding (R)-1-(1-naphthyl)ethylamine and tripotassium phosphate, heating to 70-75°C to react until the intermediate 2 is completely reacted; cooling to ≤50°C, adding water thereto, stirring thoroughly, separating the organic phase, and concentrating under reduced pressure to remove the acetonitrile to obtain intermediate 3.
[0020] Furthermore, the specific steps of S3 include: adding the unpurified intermediate 3 of S2 to anhydrous ethanol, then adding hydrochloric acid ethanol solution, stirring thoroughly, heating to 50-55°C, and stirring at this temperature until the intermediate 3 reacts completely; cooling to 0±5°C and stirring at this temperature to crystallize, filtering to obtain the filter cake, and air drying to constant weight to obtain intermediate 4.
[0021] Furthermore, the specific steps of S4 include: adding intermediate 4 to toluene, dropping NaOH solution, stirring the reaction thoroughly, separating the organic phase, and drying it over anhydrous sodium sulfate; adding an organic base, palladium acetate and X-phos thereto at -5°C to room temperature, stirring thoroughly and uniformly, controlling the internal temperature at -5°C to room temperature, and slowly dropping ethyl p-bromophenylacetate thereto, and after the addition is completed, maintaining the reaction at -5°C to room temperature and continuing to stir the reaction until the intermediate 4 is completely reacted, and post-processing and purification to obtain ivocate ethyl ester.
[0022] Preferably, the post-treatment step of S4 comprises: adding water to quench the reaction, stirring thoroughly and then separating the organic phase, washing the organic phase twice with 10% NaCl solution, concentrating under reduced pressure to remove toluene, adding 30% hydrochloric acid ethanol solution dropwise thereto, stirring thoroughly to dissolve, cooling to 0±5°C, adding methyl tert-butyl ether dropwise thereto to allow the solid to slowly precipitate, continuing to stir at 0±5°C to crystallize, filtering to obtain the filter cake, and drying to constant weight to obtain the hydrochloride of ivocate ethyl ester (intermediate 5), and further obtaining ivocate ethyl ester by adding inorganic base treatment to intermediate 5.
[0023] Furthermore, the intermediate 2 prepared by S1, the intermediate 3 prepared by S2, and the intermediate 4 prepared by S3 do not need to be purified when used as reactants in the next step.
[0024] 3. Beneficial effects:
[0025] 1. Compared with the preparation of isopropanol hydrochloride by adding acetyl chloride to isopropanol under low temperature conditions, the use of ethanol hydrochloride as a deprotection reagent significantly simplifies the operation;
[0026] 2. Compared with the isopropanol hydrochloride compound prepared by the original process, the intermediate 4 prepared by the improved process is a hydrochloride. It is difficult to remove isopropanol when the isopropanol hydrochloride compound is dried, and the ethanol in the hydrochloride is very easy to dry, thereby reducing the risk of isopropanol mixing into the coupling reaction to generate impurities;
[0027] 3. Using sodium tert-butoxide or potassium tert-butoxide instead of expensive cesium carbonate as an acid binding agent can significantly reduce material costs;
[0028] 4. Compared with the original process which requires 8 hours of reaction at 95°C to 105°C, the coupling reaction of S4 uses sodium tert-butoxide or potassium tert-butoxide as an acid-binding agent. Since sodium tert-butoxide and potassium tert-butoxide are strong organic bases, they will react with the raw material ethyl 4-bromophenylacetate under high temperature conditions. The reaction temperature is controlled at -5°C to room temperature. At this time, the coupling reaction only needs 2 to 3 hours at -5°C to room temperature to complete the reaction, which not only reduces energy consumption but also significantly accelerates the reaction speed. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The LC spectrum of the control in Example 1;
[0030] Figure 2 is the LCMS spectrum of intermediate 5 in Example 1;
[0031] Figure 3 1H-NMR spectrum of intermediate 5 in Example 1;
[0032] Figure 4 This is the central control LC spectrum of Comparative Example 2. DETAILED DESCRIPTION
[0033] The present invention will be described in detail below in conjunction with the accompanying drawings.
[0034] Embodiment 1:
[0035] A preparation method of evokedrin ethyl ester, the reaction route of the preparation method is as follows:
[0036]
[0037] The preparation method comprises the following steps:
[0038] S1: Preparation of intermediate 2: 3 kg (R)-1-BOC-3-hydroxypyrrolidine, 15 L DCM, 306 g trimethylamine hydrochloride and 2059 g triethylamine were added in sequence, the temperature was lowered to -5 to 0 ° C, the internal temperature was maintained at 5 ± 5 ° C, 3764 g 2-nitrobenzenesulfonyl chloride and 6 L DCM solution were added dropwise thereto, and the internal temperature was continued to be maintained at 5 ± 5 ° C and stirred for 1 to 2 hours until the (R)-1-BOC-3-hydroxypyrrolidine reacted completely; after the reaction was complete, 15 kg water was added thereto to quench the reaction, the temperature was restored to room temperature and stirred for 1 hour, and then the organic phase was separated; the solvent was removed by concentrating under reduced pressure at 35 to 45 ° C to obtain intermediate 2.
[0039] S2: Preparation of intermediate 3: 12 kg acetonitrile, 3155 g (R)-1-(1-naphthyl)ethylamine and 3741 g tripotassium phosphate were added to intermediate 2 in sequence, and the temperature was raised to 70-75°C for reaction for 7-9 hours until intermediate 2 was completely reacted; the temperature was lowered to ≤50°C, 30 kg water was added thereto, the organic phase was separated after sufficient stirring, and the acetonitrile was removed by concentrating under reduced pressure at 40-50°C to obtain intermediate 3.
[0040] S3: Preparation of intermediate 4. 9L of anhydrous ethanol and 3kg of 30% hydrochloric acid ethanol solution were added to intermediate 3 in sequence. After sufficient stirring, the temperature was raised to 50-55°C and kept stirring for 2-3h until the reaction of intermediate 4 was complete; the temperature was lowered to 0±5°C and kept stirring for 2h to crystallize, then the filter cake was filtered and dried at 50-55°C to constant weight to obtain 3.6kg of white solid with a purity of 99.8% and a yield of 71.7%.
[0041] S4: Preparation of intermediate 5, 3kg of intermediate 4 and 15L of toluene were added to the reactor in sequence, 15L of 5% NaOH solution was added dropwise thereto, and the organic phase was separated after sufficient stirring, and dried once with 150g of anhydrous sodium sulfate; the temperature was lowered to 0±5°C, 1830g of sodium tert-butoxide, 1.5g of palladium acetate and 9g of X-phos were added thereto, and the internal temperature was controlled at 0±5°C, and 2790g of ethyl p-bromophenylacetate was slowly added thereto, and after the addition was completed, the temperature was maintained at 0±5°C and the reaction was continued with stirring for 2 to 3h until the reaction of intermediate 4 was complete, and the LC was controlled as follows during the reaction: Figure 1 As shown, the raw material remains 0.174%, and the product: 84.935%. Add 15L of water, stir well, separate the organic phase, wash twice with 6L×2 10% NaCl solution, concentrate under reduced pressure at 60-70℃ to remove toluene, add 2kg of 30% hydrochloric acid ethanol solution, stir well to dissolve, cool to 0±5℃, add 30L of methyl tert-butyl ether to slowly precipitate solid, continue stirring and crystallizing at 0±5℃ for 2h, filter and take the filter cake, dry at 40-50℃ to constant weight, and obtain 3.1kg of off-white solid with a purity of 99.61% and a yield of 74%. LCMS is as follows Figure 2 , 1H-NMR Figure 3 Intermediate 5 is the hydrochloride of evokedil ethyl ester, which can be further treated with an inorganic base to obtain evokedil ethyl ester.
[0042] 1H-NMR (400M, DMSO) δ8.40 (d, J=8.4Hz, 1H), 8.14 (d, J=6.8Hz, 1H), 8.04 (t, J=7. 2Hz, 2H), 7.65 (m, J=8.4Hz, 3H), 7.08 (d, J=8.4Hz, 2H), 6.50 (d, J=8.4Hz, 2H), 5.4 4 (d, J=5.2Hz, 1H), 4.05 (q, J=7.2Hz, 2H), 3.84 (m, 1H), 3.49 (m, 5H), 3.18 (q, J=7. 6Hz, 1H), 2.36 (m, 1H), 2.25 (m, 1H), 1.77 (d, J=7.2Hz, 3H), 1.17 (t, J=7.2Hz, 3H). MS(ESI): m / z403(M+1).
[0043] Embodiment 2:
[0044] A method for preparing evokase ethyl ester, wherein S1-S3 are the same as those in Example 1,
[0045] S4: Preparation of intermediate 5: 10 g of intermediate 4 and 50 mL of toluene were added to the reactor in sequence, 50 mL of 5% NaOH solution was added dropwise thereto, the organic phase was separated after being fully stirred, and dried once with 5 g of anhydrous sodium sulfate; 6.1 g of sodium tert-butoxide, 0.05 g of palladium acetate and 0.3 g of X-phos were added thereto at 10-20° C., 9.3 g of ethyl p-bromophenylacetate was slowly added thereto at room temperature after being fully stirred, and after the addition was completed, the room temperature was maintained and the stirring reaction was continued for 2-3 h until the reaction of intermediate 4 was complete, 50 ml of water was added thereto, the organic phase was separated after being fully stirred, and then washed twice with 20 ml×2 10% NaCl solution, concentrated under reduced pressure at 60-70° C. to remove toluene, and 7 g of 30% hydrochloric acid ethanol solution was stirred thoroughly to dissolve, then cooled to 0±5°C, 100 ml of methyl tert-butyl ether was added dropwise to allow the solid to slowly precipitate, and stirring and crystallization continued at 0±5°C for 2 h. The filter cake was filtered and dried at 40-50°C to constant weight to obtain 9.3 g of an off-white solid with a purity of 99.46% and a yield of 66.4%.
[0046] Comparative Example 1:
[0047] A method for preparing evokase ethyl ester, wherein S1-S3 are the same as those in Example 1,
[0048] S4: Preparation of intermediate 5. 10 g of intermediate 4 and 50 mL of toluene were added to the reactor in sequence, 50 mL of 5% NaOH solution was added dropwise thereto, the organic phase was separated after sufficient stirring, and dried once with 5 g of anhydrous sodium sulfate; 6.1 g of sodium tert-butoxide, 0.05 g of palladium acetate and 0.3 g of X-phos were added thereto at 10-20° C., 9.3 g of ethyl p-bromophenylacetate was slowly added thereto at room temperature after sufficient stirring, the temperature was raised to 95° C.-105° C. and stirring was continued until the reaction of intermediate 4 was complete, 50 ml of water was added thereto, the organic phase was separated after sufficient stirring, and then washed twice with 20 ml×2 10% NaCl solution, concentrated under reduced pressure at 60-70° C. to remove toluene, 7 g of 30% hydrochloric acid ethanol solution was added thereto, the mixture was sufficiently stirred to dissolve, the temperature was lowered to 0±5° C., 100 ml of methyl tert-butyl ether was added thereto, and an oily substance was directly precipitated, and no solid was precipitated.
[0049] Comparative Example 2:
[0050] A method for preparing evokase ethyl ester, wherein S1-S3 are the same as those in Example 1,
[0051] S4: Preparation of intermediate 5: 10 g of intermediate 4 and 50 mL of toluene were added to the reactor in sequence, 50 mL of 5% NaOH solution was added dropwise thereto, the organic phase was separated after sufficient stirring, and dried once with 5 g of anhydrous sodium sulfate; 20.7 g of cesium carbonate, 0.05 g of palladium acetate and 0.3 g of X-phos were added thereto at 10-20° C., 9.3 g of ethyl p-bromophenylacetate was slowly added thereto at room temperature after sufficient stirring, and the reaction was stirred overnight at room temperature after the addition was completed. The raw materials hardly reacted, and the reaction was controlled by LC as follows: Figure 4 As shown, the raw material remains 84.18%, and the product: 4.76%.
[0052] Although the present invention has been disclosed as above in terms of preferred embodiments, they are not intended to limit the present invention. Anyone skilled in the art can make various changes or modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the scope of protection defined by the claims of this application.
Claims
1. A method for preparing evokedrin ethyl ester, characterized in that: The reaction scheme of the preparation method is as follows: The preparation method comprises the following steps: S1: (R)-1-BOC-3-hydroxypyrrolidine and 2-nitrobenzenesulfonyl chloride were reacted to prepare intermediate 2; S2: Intermediate 2 reacts with (R)-1-(1-naphthyl)ethylamine to prepare intermediate 3; S3: intermediate 3 uses hydrochloric acid ethanol solution as a deprotection reagent to prepare intermediate 4; S4: Intermediate 4 is converted from an ammonium salt to an amine by treatment with an inorganic base and then added to toluene or xylene, sodium tert-butoxide or potassium tert-butoxide is added as an acid-binding agent, palladium acetate is used as a catalyst, and X-phos is used as a ligand of the catalyst. Ethyl p-bromophenylacetate is added dropwise in the range of -5°C to room temperature for coupling reaction, and the temperature is maintained at -5°C to room temperature and stirred until the reaction is completed. Hydrochloric acid and ethanol are added dropwise to convert the product into an ammonium salt, and the temperature is lowered to 0±5°C. Methyl tert-butyl ether is added dropwise to precipitate a solid ammonium salt to obtain intermediate 5; intermediate 5 is further converted from an ammonium salt to an amine by treatment with an inorganic base to obtain ivocate ethyl ester.
2. The method for preparing evokase ethyl according to claim 1, characterized in that: The molar ratio of sodium tert-butoxide or potassium tert-butoxide to intermediate 4 is 1.2 to 1.
5.
3. The method for preparing evokase ethyl ester according to claim 1, characterized in that: The specific steps of S1 include: adding (R)-1-BOC-3-hydroxypyrrolidine to a solvent DCM, then adding trimethylamine hydrochloride and triethylamine, cooling to -5 to 0°C, maintaining the internal temperature at 5±5°C, dropwise adding a DCM solution of 2-nitrobenzenesulfonyl chloride, continuing to maintain the internal temperature at 5±5°C and stirring the reaction until the (R)-1-BOC-3-hydroxypyrrolidine reacts completely, quenching with water, separating the liquids and concentrating to obtain intermediate 2.
4. The method for preparing evokase ethyl according to claim 3, characterized in that: The specific steps of S2 include: adding the unpurified intermediate 2 of S1 to acetonitrile, then adding (R)-1-(1-naphthyl)ethylamine and tripotassium phosphate, heating to 70-75°C to react until the intermediate 2 is completely reacted; cooling to ≤50°C, adding water thereto, stirring thoroughly, separating the organic phase, and concentrating under reduced pressure to remove the acetonitrile to obtain the intermediate 3.
5. The method for preparing evokase ethyl ester according to claim 4, characterized in that: The specific steps of S3 include: adding the unpurified intermediate 3 of S2 to anhydrous ethanol, then adding hydrochloric acid ethanol solution, stirring thoroughly, heating to 50-55°C, and stirring at this temperature until the intermediate 3 is completely reacted; cooling to 0±5°C and stirring at this temperature to crystallize, filtering to obtain the filter cake, and air drying to constant weight to obtain the intermediate 4.
6. The method for preparing evokase ethyl ester according to claim 5, characterized in that: The specific steps of S4 include: adding intermediate 4 to toluene, dropping NaOH solution, stirring the reaction thoroughly, separating the organic phase, and drying it over anhydrous sodium sulfate; adding an organic base, palladium acetate and X-phos at -5°C to room temperature, stirring thoroughly, controlling the internal temperature at -5°C to room temperature, slowly dropping ethyl p-bromophenylacetate therein, and maintaining the temperature at -5°C to room temperature after the addition is completed, and continuing to stir the reaction until the reaction of intermediate 4 is complete, and performing post-treatment and purification to obtain ivocate ethyl ester.
7. The method for preparing evokase ethyl ester according to claim 6, characterized in that: The post-treatment step of S4 includes: adding water to quench the reaction, stirring thoroughly and then separating the organic phase, washing the organic phase twice with 10% NaCl solution, concentrating under reduced pressure to remove toluene, adding 30% hydrochloric acid ethanol solution dropwise thereto, stirring thoroughly to dissolve, cooling to 0±5°C, adding methyl tert-butyl ether dropwise thereto to slowly precipitate the solid, continuing to stir at 0±5°C to crystallize, filtering to obtain the filter cake, and drying to constant weight to obtain the hydrochloride of ivocate ethyl ester (intermediate 5), and treating intermediate 5 with an inorganic base to further obtain ivocate ethyl ester.
8. The method for preparing evokase ethyl ester according to claim 6, characterized in that: Intermediate 2 prepared by S1, intermediate 3 prepared by S2 and intermediate 4 prepared by S3 do not need to be purified when used as reactants in the next step.
Citation Information
Patent Citations
Novel crystalline arylalkylamine compounds and their manufacturing methods
CN105517992B
